Nacuity Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Dec 29, 2025
Total Funding Raised
$46.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that develops targeted antioxidant therapies for the treatment of ocular diseases and serious chronic conditions involving oxidative stress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nacuity Pharmaceuticals, Inc. Comparables
Compare Nacuity Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kyoto Drug Discovery & Development Co., Ltd. | 76% | |
| Kiora Pharmaceuticals | 76% | |
| Aldeyra Therapeutics | 76% |
Nacuity Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 29, 2025 | ||||
| Series B | Jun 15, 2022 | ||||
| Series A Extension | Jan 3, 2022 | ||||
| VC Round | Mar 30, 2021 | ||||
| Series A | Jan 24, 2019 | ||||
Series A | Jan 19, 2017 |
Nacuity Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Series A |
| Tarnagulla Ventures | Series A |
| Foundation Fighting Blindness | Series B, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, from 2.7K to 3.7K.
- Dec 29, 2025
$13M round led by Foundation Fighting Blindness.
Nacuity Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nacuity Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Nacuity Pharmaceuticals, Inc. a public or private company?
Nacuity Pharmaceuticals, Inc. is a private company.
What is the current stock price of Nacuity Pharmaceuticals, Inc.?
Nacuity Pharmaceuticals, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Nacuity Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Nacuity Pharmaceuticals, Inc. is not publicly available.
Can I buy Nacuity Pharmaceuticals, Inc. stock?
Nacuity Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nacuity Pharmaceuticals, Inc.'s last funding round?
Nacuity Pharmaceuticals, Inc.'s most recent funding round was Series B on June 15, 2022.
Who are the main investors in Nacuity Pharmaceuticals, Inc.?
Key investors in Nacuity Pharmaceuticals, Inc. include Foundation Fighting Blindness.
Will Nacuity Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Nacuity Pharmaceuticals, Inc..
How can I track Nacuity Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nacuity Pharmaceuticals, Inc.'s secondary market activity and sign up for updates.